Impact of baseline anti-cyclic citrullinated peptide-2...

  • Main
  • 2015 / 09
  • Impact of baseline anti-cyclic citrullinated peptide-2...

Impact of baseline anti-cyclic citrullinated peptide-2 antibody concentration on efficacy outcomes following treatment with subcutaneous abatacept or adalimumab: 2-year results from the AMPLE trial

Sokolove, Jeremy, Schiff, Michael, Fleischmann, Roy, Weinblatt, Michael E, Connolly, Sean E, Johnsen, Alyssa, Zhu, Jin, Maldonado, Michael A, Patel, Salil, Robinson, William H
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Annals of the Rheumatic Diseases
DOI:
10.1136/annrheumdis-2015-207942
Date:
September, 2015
File:
PDF, 739 KB
english, 2015
Conversion to is in progress
Conversion to is failed